chlorisondamine has been researched along with Circulatory Collapse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VERAGUT, UP | 1 |
| Altavilla, D; Bazzani, C; Bigiani, A; Bitto, A; De Meo, V; Giuliani, D; Guarini, S; Messineo, F; Minutoli, L; Mioni, C; Squadrito, F; Squadrito, G; Venuti, FS | 1 |
2 other study(ies) available for chlorisondamine and Circulatory Collapse
| Article | Year |
|---|---|
[The enzyme inhibitor Trasylol in experimental shock caused by scalding in rats. Comparison with the ganglionic blocking agent Ecolid].
Topics: Animals; Antihypertensive Agents; Aprotinin; Autonomic Agents; Burns; Chlorisondamine; Enzyme Inhibitors; Ganglionic Blockers; Kallikreins; Rats; Shock | 1962 |
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock.
Topics: Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Chlorisondamine; Electric Stimulation; I-kappa B Proteins; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Shock; Splanchnic Circulation; Tumor Necrosis Factor-alpha; Vagus Nerve | 2006 |